FindMyKOL
Clinical trialNCT06478589RecruitingPhase 2Interventional

Patient Priorities for Survivorship Care in Older Breast Cancer Survivors

SponsorThe University of Texas Health Science Center, HoustonEnrollment120Breast Cancer Survivorship
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The objective of this study is to adapt the Patient Priorities Care (PPC) framework to breast cancer survivorship via a user-centered approach, through an iterative process in which patients and their physicians help to refine and modify the intervention. A second objective is to evaluate the feasibility and effectiveness of the adapted PPC framework in breast cancer survivorship for older adults.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

  • Dana E. Giza, MD

    The University of Texas Health Science Center, Houston

    Principal Investigator

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Ut Physicians Center for Healthy Aging Bellaire

    Bellaire, Texas, United States

    Recruiting
  • Memorial Hermann Cancer Center

    Houston, Texas, United States

    Dana E Giza, MD
    Recruiting
  • Ut Physicians Family Medicine Bayshore

    Houston, Texas, United States

    Dana E Giza, MD
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
2 Jan 2025
Primary completion
1 Dec 2026
Completion
1 Jun 2027
Last update posted
12 Aug 2025
Registered enrollment
120
Registry id
NCT06478589

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 11 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.